Summary of Consolidated Financial Results for the Three Months Ended June 30, 2026 [IFRS]

(Amounts less than one million yen are rounded down to the nearest million yen.)

1. Consolidated financial results for the three months ended June 30, 2026 (from April 1, 2026 to June 30, 2026)

(1) Consolidated results of operations

(Percentage figures represent changes from the same period of the previous fiscal year.)
Three months ended	Revenue		Business contribution profit		Operating profit
Three months ended	Millions of yen	%	Millions of yen	%	Millions of yen	%
June 30, 2026	258,517	2.9	11,566	25.8	9,620	-4.4
June 30, 2025	251,204	-8.2	9,195	411.0	10,062	-

Three months ended	Profit before tax		Profit for the period		Profit attributable to owners of the Company
Three months ended	Millions of yen	%	Millions of yen	%	Millions of yen	%
June 30, 2026	7,608	-14.4	7,813	2.7	7,780	6.8
June 30, 2025	8,891	-	7,606	-	7,283	-

Three months ended	Basic earnings per share	Diluted earnings per share
Three months ended	Yen	Yen
June 30, 2026	15.74	15.68
June 30, 2025	14.74	14.70

(Notes)

1.“Business contribution profit” is calculated by deducting the cost of sales and selling, general and administrative expenses from revenue.

2.Total comprehensive income for the three months ended June 30, 2026 and 2025, was 17,893 million yen (an increase of 313.4% year-on-year) and 4,328 million yen (a decrease of 79.7% year-on-year), respectively.

3.Basic earnings per share and diluted earnings per share are calculated based on the profit attributable to owners of Konica Minolta, Inc. (the “Company”).

4.The Precision Medicine Business is classified as a discontinued operation from the three months ended December 31, 2024. As a result, revenue, business contribution profit, operating profit, and profit before tax represent the amount of continuing operations excluding the discontinued operation. Profit for the period and profit attributable to owners of the Company represent the sum of continuing operations and the discontinued operation.

(2) Consolidated financial position

As of	Total assets	Total equity	Equity attributable to owners of the Company	Equity ratio attributable to owners of the Company
As of	Millions of yen	Millions of yen	Millions of yen	%
June 30, 2026	1,229,912	563,398	550,786	44.8
March 31, 2026	1,234,909	548,971	536,505	43.4

2. Dividends per share

	End of the three-month period	End of the six-month period	End of the nine-month period	End of the year	Total
	Yen	Yen	Yen	Yen	Yen
Fiscal year ended March 31, 2026	-	5.00	-	7.00	12.00
Fiscal year ending March 31, 2027	-
Fiscal year ending March 31, 2027 (forecast)		9.00	-	9.00	18.00

(Note)Changes from the latest dividend forecasts: None

3. Consolidated forecasts for the fiscal year ending March 31, 2027 (from April 1, 2026 to March 31, 2027)

(Percentage figures represent changes from the previous fiscal year.)
Fiscal year ending	Revenue		Business contribution profit		Operating profit		Profit attributable to owners of the Company		Basic earnings per share
Fiscal year ending	Millions of yen	%	Millions of yen	%	Millions of yen	%	Millions of yen	%	Yen
March 31, 2027	1,105,000	1.6	56,000	5.3	50,000	0.3	28,500	-5.8	57.57

(Note)Changes from the latest consolidated forecasts: None

■ Notes

Significant changes in the scope of consolidation for the three months ended June 30, 2026: None
Changes in accounting policies or changes in accounting estimates
1. Changes in accounting policies required by International
  Financial Reporting Standards (IFRS): None
2. Changes in accounting policies other than the above a.: None
3. Changes in accounting estimates: None
Number of issued and outstanding shares (common stock)
1. Number of issued and outstanding shares (including treasury shares)
  As of June 30, 2026: 502,664,337 shares
  As of March 31, 2026: 502,664,337 shares
2. Number of treasury shares
  As of June 30, 2026: 7,899,641 shares
  As of March 31, 2026: 8,480,644 shares
3. Average number of issued and outstanding shares during the period
  The three months ended June 30, 2026: 494,334,247 shares
  The three months ended June 30, 2025: 494,239,924 shares

(Note)The Company has established the Board Incentive Plan. The shares owned by the trust account relating to this trust are accounted for as treasury shares (2,060,878 shares as of June 30, 2026, and 2,631,462 shares as of March 31, 2026).

■ Review procedures performed by certified public accountants or an audit firm for the attached quarterly consolidated financial statements: None

■ Explanation concerning the appropriate use of the forecasts for results of operations and other special matters

(Note on the forecasts for the consolidated financial results)

The forecasts for results of operations in this report are based on information currently available to the Company and its subsidiaries (the “Group”) and certain assumptions determined to be reasonable, and are not intended to assure any achievement of the Group’s operations. Actual results may differ significantly from the forecasts due to various factors. For further details of the assumptions that form the basis of the forecasts and other related matters when referring to the forecasts, refer to “1. OVERVIEW OF FINANCIAL RESULTS, (3) Explanation Regarding the Forecasts for the Consolidated Financial Results” in the attached Supplementary Information on page 12.

(Supplementary information for the quarterly financial results and briefing on the quarterly financial results)

The Company will hold a briefing on the quarterly financial results for institutional investors on Thursday, July 30, 2026. The proceedings and details of the briefing, along with the supplementary information on the quarterly financial results to be presented at the briefing, will be posted on the website of the Group soon after the briefing.